PTC Accounts Payable from 2010 to 2024

PTCT Stock  USD 43.23  0.34  0.79%   
PTC Therapeutics Accounts Payable yearly trend continues to be comparatively stable with very little volatility. Accounts Payable is likely to outpace its year average in 2024. Accounts Payable is the amount PTC Therapeutics owes to suppliers or vendors for products or services received but not yet paid for. It represents PTC Therapeutics' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2004-12-31
Previous Quarter
24.3 M
Current Value
13.3 M
Quarterly Volatility
8.7 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check PTC Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PTC Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 135.6 M, Total Revenue of 984.7 M or Research Development of 699.9 M, as well as many indicators such as Price To Sales Ratio of 2.09, Dividend Yield of 0.0 or Days Sales Outstanding of 51.74. PTC financial statements analysis is a perfect complement when working with PTC Therapeutics Valuation or Volatility modules.
  
Check out the analysis of PTC Therapeutics Correlation against competitors.
For more information on how to buy PTC Stock please use our How to Invest in PTC Therapeutics guide.

Latest PTC Therapeutics' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of PTC Therapeutics over the last few years. An accounting item on the balance sheet that represents PTC Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of PTC Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. PTC Therapeutics' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PTC Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

PTC Accounts Payable Regression Statistics

Arithmetic Mean9,616,453
Geometric Mean5,993,321
Coefficient Of Variation85.84
Mean Deviation6,551,070
Median6,298,000
Standard Deviation8,255,107
Sample Variance68.1T
Range26.6M
R-Value0.66
Mean Square Error41T
R-Squared0.44
Significance0.01
Slope1,227,086
Total Sum of Squares954.1T

PTC Accounts Payable History

20249.9 M
2023M
202227.3 M
202123 M
202018.7 M
201910.3 M
2018M

About PTC Therapeutics Financial Statements

PTC Therapeutics shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although PTC Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in PTC Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on PTC Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Accounts PayableM9.9 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for PTC Stock Analysis

When running PTC Therapeutics' price analysis, check to measure PTC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PTC Therapeutics is operating at the current time. Most of PTC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PTC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PTC Therapeutics' price. Additionally, you may evaluate how the addition of PTC Therapeutics to your portfolios can decrease your overall portfolio volatility.